Novo Nordisk partners with OpenAI to use AI for speeding up drug development
Danish Drugmaker Novo Nordisk said on Tuesday it is partnering with OpenAI to use artificial intelligence across its business, from drug discovery to manufacturing and commercial operations. The company, which is the maker of weight loss drugs Wegovy and …